BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25175550)

  • 1. Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats.
    Sasikumar P; Gomathi S; Anbazhagan K; Abhishek A; Paul E; Vasudevan V; Sasikumar S; Selvam GS
    J Biomed Sci; 2014 Aug; 21(1):86. PubMed ID: 25175550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered Lactobacillus plantarum WCFS1 constitutively secreting heterologous oxalate decarboxylase and degrading oxalate under in vitro.
    Sasikumar P; Gomathi S; Anbazhagan K; Baby AE; Sangeetha J; Selvam GS
    Curr Microbiol; 2014 Nov; 69(5):708-15. PubMed ID: 24989485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro degradation of oxalate by recombinant Lactobacillus plantarum expressing heterologous oxalate decarboxylase.
    Anbazhagan K; Sasikumar P; Gomathi S; Priya HP; Selvam GS
    J Appl Microbiol; 2013 Sep; 115(3):880-7. PubMed ID: 23734819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of biologically active heterologous oxalate decarboxylase (OxdC) in Lactobacillus plantarum WCFS1 using homologous signal peptides.
    Sasikumar P; Gomathi S; Anbazhagan K; Selvam GS
    Biomed Res Int; 2013; 2013():280432. PubMed ID: 23971028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal integration of heterologous oxalate decarboxylase in Lactobacillus plantarum WCFS1 using mobile genetic element Ll.LtrB.
    Paul E; Albert A; Ponnusamy S; Venkatesan S; Govindan Sadasivam S
    Arch Microbiol; 2019 May; 201(4):467-476. PubMed ID: 30349983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased abundance of bacteria of the family Muribaculaceae achieved by fecal microbiome transplantation correlates with the inhibition of kidney calcium oxalate stone deposition in experimental rats.
    Wang Y; Sun J; Xie S; Zhou Y; Wang T; Liu Z; Li C; Gao L; Pan T
    Front Cell Infect Microbiol; 2023; 13():1145196. PubMed ID: 37313343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile group II intron based gene targeting in Lactobacillus plantarum WCFS1.
    Sasikumar P; Paul E; Gomathi S; Abhishek A; Sasikumar S; Selvam GS
    J Basic Microbiol; 2016 Oct; 56(10):1107-1116. PubMed ID: 27119622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and Characterization of Lactobacillus paragasseri and Lacticaseibacillus paracasei: Two Probiotic Bacteria that Can Degrade Intestinal Oxalate in Hyperoxaluric Rats.
    Mehra Y; Rajesh NG; Viswanathan P
    Probiotics Antimicrob Proteins; 2022 Oct; 14(5):854-872. PubMed ID: 35699895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalate-Degrading Enzyme Recombined Lactic Acid Bacteria Strains Reduce Hyperoxaluria.
    Zhao C; Yang H; Zhu X; Li Y; Wang N; Han S; Xu H; Chen Z; Ye Z
    Urology; 2018 Mar; 113():253.e1-253.e7. PubMed ID: 29198849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous expression of oxalate decarboxylase in Lactobacillus plantarum NC8.
    Kolandaswamy A; George L; Sadasivam S
    Curr Microbiol; 2009 Feb; 58(2):117-21. PubMed ID: 18946701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
    Li Y; McMartin KE
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats.
    Zuo J; Khan A; Glenton PA; Khan SR
    Nephrol Dial Transplant; 2011 Jun; 26(6):1785-96. PubMed ID: 21378157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
    Khan SR; Glenton PA; Byer KJ
    Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
    Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
    Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model.
    Zhu W; Xu YF; Feng Y; Peng B; Che JP; Liu M; Zheng JH
    Urolithiasis; 2014 Dec; 42(6):519-26. PubMed ID: 25085199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.